[L-Dopa in the treatment of Parkinson's disease. (Considerations on 51 cases)].
D000367:Age Factors; D000368:Aged; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006948:Hyperkinesis / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010300:Parkinson Disease / Q000188:drug therapy*; D013997:Time Factors; D014202:Tremor / Q000188:drug therapy
D004295:Dihydroxyphenylalanine
La levodopa nel trattamento del morbo di Parkinson. (Considerazioni su 51 casi)